SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19
2020 · Journal of Hematology & Oncology · 673 citations
https://doi.org/10.1186/s13045-020-00954-7
J
Jianzeng Dong
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
687
Papers
8.8K
Citations
44
h-index
219
i10-index
Jianzeng Dong is an academic researcher from Capital University. The author has contributed to research in topics: Atrial Fibrillation Management and Outcomes & Cardiac Arrhythmias and Treatments & Cardiac electrophysiology and arrhythmias. The author has an h-index of 44, co-authored 584 publications.
ORCID: 0000-0001-7299-7805Papers by this author
worksRe-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
2017 · Nature Communications · 173 citations
https://doi.org/10.1038/s41467-017-01385-8
Rationale and design of the Chinese Atrial Fibrillation Registry Study
2016 · BMC Cardiovascular Disorders · 80 citations
https://doi.org/10.1186/s12872-016-0308-1
HATCH score in the prediction of new-onset atrial fibrillation after catheter ablation of typical atrial flutter
2015 · Heart Rhythm · 74 citations
https://doi.org/10.1016/j.hrthm.2015.04.008
Pulmonary Vein Isolation With Optimized Linear Ablation vs Pulmonary Vein Isolation Alone for Persistent AF
2024 · JAMA · 67 citations
https://doi.org/10.1001/jama.2024.24438
Association Between Blood Lipid Profiles and Atrial Fibrillation: A Case-Control Study
2018 · Medical Science Monitor · 47 citations
https://doi.org/10.12659/msm.907580
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat